 SAN DIEGO, Nov. 9, 2020 PRNewswire -- Neurocrine Biosciences, Inc. Nasdaq: NBIX today announced that Neurocrine Biosciences management will present at the following investor conferences: Kevin Gorman, Chief Executive Officer, and Kyle Gano, Chief Business Development and Strategy... 